Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

February 15, 2017

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Atrial FibrillationVenous ThromboembolismPulmonary Embolism
Interventions
OTHER

XAPPORT

A mobile device app based on different guidelines provides adequate guidance to physicians attending patients undergoing elective surgery, who have to interrupt treatment with rivaroxaban for surgery, in deciding how to approach the pre- and postoperative management of anticoagulation.

OTHER

"Expert Panel (gold standard)"

A national panel of experts comprising anesthetists and surgeons from various disciplines advised in developing an algorithm supporting physicians how to approach the perioperative management of anticoagulation in patients receiving rivaroxaban and requiring elective surgery.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

Bayer

INDUSTRY